Microsoft Excel LibreOffice Calc

Statement of Cash Flows

Difficulty: Beginner

The cash flow statement provides information about a company's cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company's statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Abbott Laboratories, Consolidated Statement of Cash Flows

USD $ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Net earnings 477  1,400  4,423  2,284  2,576 
Depreciation 1,046  803  871  918  928 
Amortization of intangible assets 1,975  550  601  630  791 
Share-based compensation 406  310  292  246  262 
Impact of currency devaluation 480 
Amortization of inventory step-up 907 
Investing and financing (gains) losses, net 47  86  (18) 69 
Amortization of bridge financing fees 165 
Net loss on extinguishment of debt 18 
Gains on sale of businesses (1,163) (25) (2,840)
Mylan N.V. equity investment adjustment 947 
Gain on sale of Mylan N.V. shares (45) (207)
Trade receivables (207) (177) (171) (195) (113)
Inventories 249  (98) (257) (297) (154)
Prepaid expenses and other assets 109  113  57  30  131 
Trade accounts payable and other liabilities 615  (652) (742) (225) (436)
Income taxes 1,149  (699) 957  197  (665)
(Increase) decrease in operating capital 1,915  (1,513) (156) (490) (1,237)
Adjustments to reconcile earnings to net cash from operating activities 5,093  1,803  (1,457) 1,391  748 
Net cash from operating activities 5,570  3,203  2,966  3,675  3,324 
Acquisitions of property and equipment (1,135) (1,121) (1,110) (1,077) (1,145)
Acquisitions of businesses and technologies, net of cash acquired (17,183) (80) (235) (3,317) (580)
Proceeds from business dispositions 6,042  25  230 
Proceeds from the sale of Mylan N.V. shares 2,704  2,290 
Purchases of investment securities (210) (2,823) (4,933) (1,507) (10,064)
Proceeds from sales of investment securities 129  3,709  4,112  5,624  7,839 
Other 35  42  52  70  21 
Net cash (used in) from investing activities (9,618) (248) 406  (202) (3,929)
Proceeds from issuance (repayments) of short-term debt and other (1,034) (1,767) (1,281) 1,343  2,086 
Proceeds from issuance of long-term debt and debt with maturities over 3 months 6,742  14,934  2,485 
Repayments of long-term debt and debt with maturities over 3 months (8,650) (12) (57) (577) (303)
Payment of bridge financing fees (170)
Purchase of Alere preferred stock (710)
Acquisition and contingent consideration payments related to business acquisitions (13) (25) (17) (400) (495)
Transfer of cash and cash equivalents to AbbVie Inc. (5,901)
Purchases of common shares (117) (522) (2,237) (2,195) (1,605)
Proceeds from stock options exercised 350  248  314  429  395 
Dividends paid (1,849) (1,539) (1,443) (1,342) (882)
Net cash from (used in) financing activities (5,281) 11,147  (2,236) (2,742) (6,696)
Effect of exchange rate changes on cash and cash equivalents 116  (483) (198) (143) (26)
Net increase (decrease) in cash and cash equivalents (9,213) 13,619  938  588  (7,327)
Cash and cash equivalents, beginning of year 18,620  5,001  4,063  3,475  10,802 
Cash and cash equivalents, end of year 9,407  18,620  5,001  4,063  3,475 
Source: Abbott Laboratories, Annual Reports
Item Description The company
Net cash from operating activities The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. Abbott Laboratories's net cash from operating activities increased from 2015 to 2016 and from 2016 to 2017.